Efficacy prediction of neoadjuvant cadonilimab plus FLOT therapy for advanced gastric cancer: a study based on body composition changes.

Front Oncol · 2025 · PMC12401706 · PMID 40904512

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Effect size and post hoc power analysis For variables that did not reach statistical significance (e.g., ΔBFM, ΔPBF, ΔWHR), Cohen’s d was calculated to quantify the magnitude of differences.

also in 111,027 other papers

a decreasing trendno p-value reported

LBM, SLM and SMM showed a decreasing trend in both groups and the reduction was greater in the no-progression group than in the objective response group; VFA expressed a significant reduction in the objective response group, but it tended to increase in the no-progression group; IMPEDANCE showed a significant increase in the objective response group, but the change was insignificant in the no-progression group.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.